{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:20:59Z","timestamp":1789597259711,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["psy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.psychres.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T01:47:04Z","timestamp":1469238424000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Lower folate levels in schizophrenia: A meta-analysis"],"prefix":"10.1016","volume":"245","author":[{"given":"Bing","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-Lai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2016.03.003_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/pop.2009.0063","article-title":"Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia","volume":"13","author":"Abouzaid","year":"2010","journal-title":"Popul. Health Manag."},{"key":"10.1016\/j.psychres.2016.03.003_bib2","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.clinbiochem.2007.06.001","article-title":"Associations of blood homocysteine concentrations in Arab schizophrenic patients","volume":"40","author":"Akanji","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.psychres.2016.03.003_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1475-2891-13-91","article-title":"Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review","volume":"13","author":"Arroll","year":"2014","journal-title":"Nutr. J."},{"key":"10.1016\/j.psychres.2016.03.003_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00406-012-0302-2","article-title":"Homocysteine and cognition in first-episode psychosis patients","volume":"262","author":"Ayesa-Arriola","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2016.03.003_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.psychres.2010.04.008","article-title":"Plasma homocysteine in schizophrenia: determinants and clinical correlations in Tunisian patients free from antipsychotics","volume":"179","author":"Bouaziz","year":"2010","journal-title":"Psychiatr. Res"},{"key":"10.1016\/j.psychres.2016.03.003_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40263-014-0172-4","article-title":"Vitamin supplementation in the treatment of schizophrenia","volume":"28","author":"Brown","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2016.03.003_bib7","first-page":"990","article-title":"Changes of cortical thickness in drug naive first episode schizophrenia and their correlations with serum folate, homocysteine, BDNF levels","volume":"94","author":"Chen","year":"2014","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.psychres.2016.03.003_bib8","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.3390\/nu5114760","article-title":"Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects","volume":"5","author":"Czeizel","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.psychres.2016.03.003_bib9","first-page":"513","article-title":"Serum total homocystein, folate and vitamin B12 levels and their correlation with antipsychotic drug doses in adult male patients with chronic schizophrenia","volume":"56","author":"Eren","year":"2010","journal-title":"Clin. Lab."},{"key":"10.1016\/j.psychres.2016.03.003_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrfmmm.2011.11.003","article-title":"Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity","volume":"733","author":"Fenech","year":"2012","journal-title":"Mutat. Res"},{"key":"10.1016\/j.psychres.2016.03.003_bib11","first-page":"40","article-title":"Homocysteine, folate and vitamin B12 and the association with schizophrenia","volume":"35","author":"Feng","year":"2009","journal-title":"Chin. J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2016.03.003_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jpsychires.2009.10.011","article-title":"Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia","volume":"44","author":"Garcia-Miss Mdel","year":"2010","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.psychres.2016.03.003_bib13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.psychres.2013.08.016","article-title":"Elevated homocysteine level in siblings of patients with schizophrenia","volume":"210","author":"Geller","year":"2013","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.psychres.2016.03.003_bib14","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.pnpbp.2007.05.011","article-title":"Plasma homocysteine, folate and B12 in chronic schizophrenia","volume":"31","author":"Haidemenos","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.03.003_bib15","first-page":"2897","article-title":"Association of serum folic acid and homocysteine levels and 5,10-methylenetetrahydrofolate reductase gene polymorphism with schizophrenia","volume":"94","author":"Hei","year":"2014","journal-title":"Natl. Med. J. China"},{"key":"10.1016\/j.psychres.2016.03.003_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4306\/pi.2011.8.2.134","article-title":"Serum homocysteine and folate levels in korean schizophrenic patients","volume":"8","author":"Kim","year":"2011","journal-title":"Psychiatry Invest."},{"key":"10.1016\/j.psychres.2016.03.003_bib17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.pnpbp.2005.06.029","article-title":"High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model","volume":"29","author":"Levine","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.03.003_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biopsych.2005.10.009","article-title":"Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia","volume":"60","author":"Levine","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.03.003_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.encep.2010.12.004","article-title":"Hyperhomocysteinemia and schizophrenia: case control study","volume":"37","author":"Mabrouk","year":"2011","journal-title":"Encephale"},{"key":"10.1016\/j.psychres.2016.03.003_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpsychires.2014.03.021","article-title":"Humanistic burden in schizophrenia: a literature review","volume":"54","author":"Millier","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2016.03.003_bib21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11011-014-9534-3","article-title":"Elevated homocysteine level in first-episode schizophrenia patients--the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse","volume":"29","author":"Misiak","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.psychres.2016.03.003_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neubiorev.2014.08.006","article-title":"B vitamin polymorphisms and behavior: evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline","volume":"47","author":"Mitchell","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psychres.2016.03.003_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnbeh.2014.00343","article-title":"Homocysteine levels in schizophrenia and affective disorders-focus on cognition","volume":"8","author":"Moustafa","year":"2014","journal-title":"Front Behav. Neurosci."},{"key":"10.1016\/j.psychres.2016.03.003_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-3956(74)90101-0","article-title":"N-5,10-methylenetetrahydrofolate reductase deficiency and schizophrenia: a working hypothesis","volume":"11","author":"Mudd","year":"1974","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.psychres.2016.03.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(03)00200-2","article-title":"Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia","volume":"121","author":"Muntjewerff","year":"2003","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2016.03.003_bib26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.euroneuro.2010.10.001","article-title":"Effects of season of birth and a common MTHFR gene variant on the risk of schizophrenia","volume":"21","author":"Muntjewerff","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2016.03.003_bib27","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/schbul\/sbt154","article-title":"Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia","volume":"40","author":"Nishi","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2016.03.003_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1258\/acb.2007.007057","article-title":"Altered red cell membrane compositions related to functional vitamin B(12) deficiency manifested by elevated urine methylmalonic acid concentrations in patients with schizophrenia","volume":"45","author":"Ozcan","year":"2008","journal-title":"Ann. Clin. Biochem"},{"key":"10.1016\/j.psychres.2016.03.003_bib29","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.pnpbp.2008.09.009","article-title":"Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia","volume":"32","author":"Petronijevic","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.03.003_bib30","first-page":"1140","article-title":"Relashionship between plasma homocysteine, serum folate levels and first-episode schizophrenia patients","volume":"29","author":"Qian","year":"2009","journal-title":"HangZhou Univ. J. Med. Sci."},{"key":"10.1016\/j.psychres.2016.03.003_bib31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2013.900","article-title":"Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia","volume":"70","author":"Roffman","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2016.03.003_bib32","first-page":"S437","article-title":"Folate and vitamin B12 status in schizophrenic patients","volume":"16","author":"Saedisomeolia","year":"2011","journal-title":"J. Res Med. Sci."},{"key":"10.1016\/j.psychres.2016.03.003_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.schres.2014.07.033","article-title":"Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naive, first episode schizophrenia","volume":"159","author":"Song","year":"2014","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.psychres.2016.03.003_bib34","first-page":"603","article-title":"Changes of levels of plasma hydrogensulfide, homocysteine, folic acid and vitamin B6 in schizophrenia patients","volume":"27","author":"Zhang","year":"2010","journal-title":"J. Xinxiang Med. Coll."},{"key":"10.1016\/j.psychres.2016.03.003_bib35","first-page":"652","article-title":"Cognitive function in the first-episode schizophrenics and its association w ith serum level of homocysteine","volume":"33","author":"Zhang","year":"2007","journal-title":"Chin. J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2016.03.003_bib36","first-page":"355","article-title":"Serum level of homocysteine in the first-episode schizophrenics and its correlation w ith P300","volume":"36","author":"Zhu","year":"2010","journal-title":"Chin. J. Nerv. Ment. Dis."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115301980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115301980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T04:28:26Z","timestamp":1536553706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178115301980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":36,"alternative-id":["S0165178115301980"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2016.03.003","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower folate levels in schizophrenia: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2016.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}